Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Lembke

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
AMIA ... Annual Symposium Proceedings. AMIA Symposium|January 15, 2024
Predicting premature discontinuation of medication for opioid use disorder from electronic medical recordsIvan Lopez, Sajjad Fouladvand, Scott Kollins, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)|March 5, 2026
A missed opportunity: a retrospective cohort study of alcohol use disorder pharmacotherapy in hospitalized patientsMichka Nazon, Paola Lavin, C William Pike, et al.
Medrxiv : the Preprint Server for Health Sciences|July 15, 2024
Which social media platforms facilitate monitoring the opioid crisis?Kristy A Carpenter, Anna T Nguyen, Delaney A Smith, et al.
Journal of Psychiatric Research|January 11, 2014
Plasma oxytocin concentrations are lower in depressed vs. healthy control women and are independent of cortisolKaeli W Yuen, Joseph P Garner, Dean S Carson, et al.
BMJ Open|March 20, 2026
The Montreal model of ketamine-therapy for alcohol use disorder and comorbid treatment-resistant depression: protocol for a feasibility trialChristina McAnulty, Philippe Lavoie, Samuel Cyr, et al.
BMJ Open|July 1, 2016
Retrospective analysis of changing characteristics of treatment-seeking smokers: implications for further reducing smoking prevalenceTeresa M Leyro, Erin E Crew, Susan W Bryson, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|September 30, 2025
Heart transplant outcomes in patients with substance use disorder history: a nationwide cohort study using high-dimensional propensity score matchingKellie Elkrief, Paola Lavin, Kyle T Greenway, et al.
Journal of General Internal Medicine|November 14, 2019
Patterns of Opioid and Benzodiazepine Use in Opioid-Naïve Patients with Newly Diagnosed Low Back and Lower Extremity PainTej D Azad, Yi Zhang, Martin N Stienen, et al.
Journal of the American Medical Informatics Association : JAMIA|September 22, 2025
Predicting treatment retention in medication for opioid use disorder: a machine learning approach using NLP and LLM-derived clinical featuresFateme Nateghi Haredasht, Ivan Lopez, Steven Tate, et al.
Addiction (Abingdon, England)|June 26, 2024
Predictability of buprenorphine-naloxone treatment retention: A multi-site analysis combining electronic health records and machine learningFateme Nateghi Haredasht, Sajjad Fouladvand, Steven Tate, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
AMIA ... Annual Symposium Proceedings. AMIA Symposium|January 15, 2024
Predicting premature discontinuation of medication for opioid use disorder from electronic medical recordsIvan Lopez, Sajjad Fouladvand, Scott Kollins, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)|March 5, 2026
A missed opportunity: a retrospective cohort study of alcohol use disorder pharmacotherapy in hospitalized patientsMichka Nazon, Paola Lavin, C William Pike, et al.
Medrxiv : the Preprint Server for Health Sciences|July 15, 2024
Which social media platforms facilitate monitoring the opioid crisis?Kristy A Carpenter, Anna T Nguyen, Delaney A Smith, et al.
Journal of Psychiatric Research|January 11, 2014
Plasma oxytocin concentrations are lower in depressed vs. healthy control women and are independent of cortisolKaeli W Yuen, Joseph P Garner, Dean S Carson, et al.
BMJ Open|March 20, 2026
The Montreal model of ketamine-therapy for alcohol use disorder and comorbid treatment-resistant depression: protocol for a feasibility trialChristina McAnulty, Philippe Lavoie, Samuel Cyr, et al.
BMJ Open|July 1, 2016
Retrospective analysis of changing characteristics of treatment-seeking smokers: implications for further reducing smoking prevalenceTeresa M Leyro, Erin E Crew, Susan W Bryson, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|September 30, 2025
Heart transplant outcomes in patients with substance use disorder history: a nationwide cohort study using high-dimensional propensity score matchingKellie Elkrief, Paola Lavin, Kyle T Greenway, et al.
Journal of General Internal Medicine|November 14, 2019
Patterns of Opioid and Benzodiazepine Use in Opioid-Naïve Patients with Newly Diagnosed Low Back and Lower Extremity PainTej D Azad, Yi Zhang, Martin N Stienen, et al.
Journal of the American Medical Informatics Association : JAMIA|September 22, 2025
Predicting treatment retention in medication for opioid use disorder: a machine learning approach using NLP and LLM-derived clinical featuresFateme Nateghi Haredasht, Ivan Lopez, Steven Tate, et al.
Addiction (Abingdon, England)|June 26, 2024
Predictability of buprenorphine-naloxone treatment retention: A multi-site analysis combining electronic health records and machine learningFateme Nateghi Haredasht, Sajjad Fouladvand, Steven Tate, et al.
Pageof 5